A double-blind, randomized, parallel study of IV dolasetron mesilate versus IV metoclopramide in patients receiving moderately emetogenic chemotherapy

Cancer Journal

Volumn 9, Issue 4, 1996, Pages 196-202

  Fauser, A A ^a   Bleiberg, H ^a   Chevallier, B ^a   Favre, R ^a   Fabbro, M ^a   Noble, A ^a   Cupissol, D ^a   Degardin, M ^a   Cappelaere, P ^a   Spaeth, D ^a   Claverie, N ^a  

^a Klinik fur Hematologie Oncologie   (Germany)

Author keywords

antiemetic; dolasetron mesilate; metoclopramide; moderately emetogenic chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOLASETRON MESILATE; DOXORUBICIN; EPIRUBICIN; FOTEMUSTINE; METOCLOPRAMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HOT FLUSH; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 9444240942     PISSN: 07657846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)